PharmaShots | Incisive News in 3 Shots

Subscribe Now

MaxCyte

PharmaShots Weekly Snapshots (April 01 – April 05, 2024)

PharmaShots Weekly Snapshots (April 01 – April 05, 2024)

April 5, 2024

MaxCyte and Be Biopharma Collaborate to Develop Engineered B Cell Medicines (BCMs)

MaxCyte and Be Biopharma Collaborate to Develop Engineered B Cell Medicines (BCMs)

April 3, 2024

MaxCyte Signed a Non-Exclusive License Agreement with Vertex to Advance CTX001 Transfusion-Dependent Beta Thalassemia or Sickle Cell Disease

MaxCyte Signed a Non-Exclusive License Agreement with Vertex to Advance CTX001 Transfusion-Dependent Beta Thalassemia or Sickle Ce...

September 29, 2022

MaxCyte Signs a Strategic Platform License with Intima Bioscience to Boost Tumor Infiltrating Lymphocytes Programs for Solid Tumor Cancer

MaxCyte Signs a Strategic Platform License with Intima Bioscience to Boost Tumor Infiltrating Lymphocytes Programs for Solid Tumor...

February 1, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us